Cabometyx 20 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FDM24
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,265
Award facts
- Contract value 100% obligated
- $33,265.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,265.08 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 24, 2025, for the supply of Cabometyx 20 mg tablets (30-count units). The order, which carries an ultimate completion date of September 25, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and extending through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has maintained consistent contract performance with DLA across various therapeutic categories, from oncology treatments to vaccines and specialty medications. The company's robust portfolio demonstrates its established capability to deliver both branded and generic prescription drugs to military health facilities. This particular delivery order for Cabometyx, a targeted cancer therapy, exemplifies the company's role in supplying essential pharmaceutical products that support the medical needs of the Defense Department's healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDM24?
SPE2DB25FDM24 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FDM24 worth?
The government has obligated $33,265 on SPE2DB25FDM24.
Is contract SPE2DB25FDM24 an order under another contract?
Yes. SPE2DB25FDM24 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM24 competed?
The extent of competition for SPE2DB25FDM24 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award